Dr. Mali's Top 5 Predictions in Ophthalmology for 2023

<p>In this episode, I share my top five predictions for 2023 in the field of ophthalmology.</p> <p><em>Brought to you by Alcon</em></p> <ul> <li>Welcome to another exciting episode of Eye Care insider <strong><em>:52</em></strong></li> <li>My review of the top five predictions in ophthalmology <strong><em>1:03</em></strong></li> <li>Prediction #1 – Vabysmo and anti-VEGF market <strong><em>1:53</em></strong></li> <li>Prediction #2 – FDA approval for GA treatment <strong><em>4:26</em></strong></li> <li>Prediction #3 – <a href="http://www.snapseyeshield.com">SNAPS eye shield</a> for ocular protection <strong><em>6:06</em></strong></li> <li>Prediction #4 – biosimilars and the ophthalmic therapeutic marketplace <strong><em>10:08</em></strong></li> <li>Prediction #5 – retina analytical tools <strong><em>12:27</em></strong></li> <li>Thanks for listening <strong><em>14:30</em></strong></li> </ul> <p>We’d love to hear from you! Send your comments/questions to Dr. Mali at <a href= "mailto:eyecareinsider@healio.com">eyecareinsider@healio.com</a>. Follow us on Twitter <a href= "https://twitter.com/HRheuminations">@Healio_OSN</a>.</p> <p><strong>Disclosures:</strong> Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; consultant/speaker for Genentech and Roche; equity owner for SNAPS; and grant/consultant for RetinAI.</p>